نتایج جستجو برای: rara positive apl

تعداد نتایج: 662831  

Journal: :Blood 2011
Julien Ablain Hugues de The

As the result of intense clinical and basic research, acute promyelocytic leukemia (APL) has progressively evolved from a deadly to a curable disease. Historically, efforts aimed at understanding the molecular bases for therapy response have repeatedly illuminated APL pathogenesis. The classic model attributes this therapeutic success to the transcriptional reactivation elicited by retinoic aci...

2006
Elizabeth A MACINTYRE Elise CHAPIRO Eric DELABESSE Vahid ASNAFI Corinne MILLIEN Frederic DAVI Elise Chapiro Eric Delabesse Vahid Asnafi Corinne Millien Frédéric Davi Elizabeth Nugent Kheira Beldjord Torsten Haferlach David Grimwade Elizabeth Macintyre

Acute promyelocytic leukemia (APL) is the most differentiated form of acute myeloid leukemia (AML) and has generally been considered to result from transformation of a committed myeloid progenitor. Paradoxically, APL has long been known to express the T-cell lymphoid marker, CD2. We searched for other parameters indicative of T-cell lymphoid specification in a cohort of 36 APL cases, revealing ...

2002
Clara Nervi Angelika Rosenauer Laura Benedetti Yury Monczak Mark Pearson Pier Giuseppe Pelicci

Acute promyelocytic leukemia (APL) is characterized by the translocation, t(15;17) and the expression of a PMLIRARa fusion protein that is diagnostic of the disease. There is evidence that PMLlRARa protein acts as a dominant negative inhibitor of normal retinoid receptor function and myeloid differentiation. We now show that the PMLlRARa fusion product is directly downregulated in response to r...

2006
Yasuomi FUKAI Miyuki HIRATA Mayumi UENO Naoaki ICHIKAWA Hikaru KOBAYASHI Hiroshi SAITOH Teruaki SAKURAI Kenji KINOSHITA Toshikazu KAISE Shin OHTA

in the French–American and British (FAB) classification and represents approximately 5—10% of all leukemia in adults. In about 95—98% of the cases, APL is associated with the reciprocal translocation, t(15; 17)(q22; q21) and the reciprocal fusion of the retinoic acid receptor (RAR)a gene on chromosome 17 with the promyelocytic leukemia (PML) gene on chromosome 15. The resulting PML-RARa fusion ...

Journal: :iranian journal of immunology 0
ali deeb department of internal medicine said hamdoun department of rheumatology khaled dababo department of laboratory in aleppo university, aleppo, syria

background: antiphospholipid antibodies (apl) are a heterogeneous family of anti-bodies associated with thrombosis and other complications. objective: to study the prevalence of apl in patients with thrombosis at aleppo university hospitals, syria. methods: one hundred and fifty-seven patients with venous and arterial thrombosis and 63 healthy controls were studied. anticardiolipin antibodies (...

Ali Deeb, Khaled Dababo Said Hamdoun

Background: Antiphospholipid antibodies (aPL) are a heterogeneous family of anti-bodies associated with thrombosis and other complications. Objective: To study the prevalence of aPL in patients with thrombosis at Aleppo University Hospitals, Syria. Methods: One hundred and fifty-seven patients with venous and arterial thrombosis and 63 healthy controls were studied. Anticardiolipin antibodies (...

2013
Hee-Jeong Lee Hyung-Jin Park Hyun-Wook Kim Sang-Gon Park

BACKGROUND Acute promyelocytic leukemia (APL) is an acute myeloid leukemia (AML) subtype with distinctive cell morphology, molecular presentation, clinical course, and treatment. About 90% of APL patients present with hemorrhagic complications due to disseminated intravascular coagulation (DIC). When APL is suspected, all-trans retinoic acid (ATRA) treatment is recommended even before confirmat...

Journal: :Blood 2006
Elise Chapiro Eric Delabesse Vahid Asnafi Corinne Millien Frederic Davi Elizabeth Nugent Kheira Beldjord Torsten Haferlach David Grimwade Elizabeth A Macintyre

Acute promyelocytic leukemia (APL) is the most differentiated form of acute myeloid leukemia (AML) and has generally been considered to result from transformation of a committed myeloid progenitor. Paradoxically, APL has long been known to express the T-cell lymphoid marker, CD2. We searched for other parameters indicative of T-cell lymphoid specification in a cohort of 36 APL cases, revealing ...

2017
Nélida I. Noguera Elvira Pelosi Daniela F. Angelini Maria Liliana Piredda Gisella Guerrera Eleonora Piras Luca Battistini Lauretta Massai Anna Berardi Gianfranco Catalano Laura Cicconi Germana Castelli Agnese D’Angiò Luca Pasquini Grazia Graziani Giuseppe Fioritoni Maria Teresa Voso Domenico Mastrangelo Ugo Testa Francesco Lo-Coco

The use of high-dose ascorbate (ASC) for the treatment of human cancer has been attempted several decades ago and has been recently revived by several in vitro and in vivo studies in solid tumors. We tested the cytotoxic effects of ASC, alone or in combination with arsenic trioxide (ATO) in acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Leukemic cell lines and primary blas...

2014
Christelle Richard Nicolas Couturier Olivier Roitel Gunther Knierim Benoit Thouvenot Catherine Astier Françoise Codreanu Gisèle Kanny Denise-Anne Moneret-Vautrin Bernard Bihain Sandrine Jacquenet

Accurate in-vitro component-based diagnosis will allow clinicians to focus their efforts toward complex issues such as disease severity and reactive dose evaluation as well as establishing effective eviction measures. However to achieve this, clinical utility of component-resolved peanut allergy testing must be rigorously evaluated. In this pilot study, we compared performances of 2 component-r...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید